We are live on
!
Find out more
FO
FT Options Portfolio holdings
AUM
$66.4M
1-Year Est. Return
18.48%
This Fund
S&P 500
This Quarter
Est. Return
+24.92%
1 Year Est. Return
+18.48%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$126M
AUM Growth
+$9.73M
(+8.4%)
Cap. Flow
+$224M
Cap. Flow
% of AUM
177.31%
Top 10 Holdings %
Top 10 Hldgs %
37.67%
Holding
493
New
153
Increased
113
Reduced
67
Closed
127
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$3.82M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$2.47M |
| 3 |
iShares Biotechnology ETF
IBB
|
+$2M |
| 4 |
Ulta Beauty
ULTA
|
+$1.86M |
| 5 |
MON
Monsanto Co
MON
|
+$1.82M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MDVN
MEDIVATION, INC.
MDVN
|
+$7.18M |
| 2 |
Biogen
BIIB
|
+$4.33M |
| 3 |
Cal-Maine
CALM
|
+$3.64M |
| 4 |
Apple
AAPL
|
+$2.74M |
| 5 |
ALR
Alere Inc
ALR
|
+$2.22M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 39.95% |
| 2 | Consumer Staples | 5.72% |
| 3 | Consumer Discretionary | 5.14% |
| 4 | Technology | 3.35% |
| 5 | Materials | 2.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
PUT
Corning
GLW
$133B
| $29K | 0.02% |
+45,000
| New | +$1M |
|
252
PUT
Target
TGT
$63.4B
| $29K | 0.02% |
40,000
+35,000
| +700% | +$2.51M |
|
253
CALL
Five Below
FIVE
$11.2B
| $28K | 0.02% |
19,600
+10,000
| +104% | +$463K |
|
254
PUT
Workday
WDAY
$35.8B
| $27K | 0.02% |
+8,400
| New | +$700K |
|
|
255
CALL
Corning
GLW
$133B
| $26K | 0.02% |
+45,000
| New | +$1M |
|
|
NYMX
256
PUT
DELISTED
Nymox Pharmaceutical Corp
NYMX
| $26K | 0.02% |
+10,000
| New | +$32.7K |
|
257
PUT
Mattel
MAT
$4.16B
| $25K | 0.02% |
23,500
+19,500
| +488% | +$638K |
|
258
PUT
AT&T
T
$152B
| $25K | 0.02% |
32,438
-154,378
| -83% | -$4.88M |
|
259
PUT
State Street SPDR S&P Biotech ETF
XBI
$10.4B
| $25K | 0.02% |
+85,000
| New | +$5.26M |
|
260
Yelp
YELP
$1.44B
| $25K | 0.02% |
+600
| New | +$21K |
|
|
N
261
CALL
DELISTED
Netsuite Inc
N
| $24K | 0.02% |
12,000
+2,000
| +20% | +$202K |
|
262
PUT
Johnson Controls International
JCI
$85.7B
| $23K | 0.02% |
+37,050
| New | +$1.72M |
|
263
PUT
Skyworks Solutions
SWKS
$8.93B
| $23K | 0.02% |
+5,000
| New | +$349K |
|
264
CALL
TJX Companies
TJX
$171B
| $23K | 0.02% |
140,000
+60,000
| +75% | +$2.35M |
|
265
PUT
Ambarella
AMBA
$2.71B
| $22K | 0.02% |
+12,500
| New | +$783K |
|
266
PUT
MannKind Corp
MNKD
$1.25B
| $22K | 0.02% |
10,200
| – | – |
|
267
CALL
Texas Instruments
TXN
$258B
| $22K | 0.02% |
7,100
-62,100
| -90% | -$4.23M |
|
268
CALL
Clorox
CLX
$11.6B
| $21K | 0.02% |
66,600
-73,700
| -53% | -$9.65M |
|
269
PUT
Qualcomm
QCOM
$181B
| $21K | 0.02% |
31,400
+15,000
| +91% | +$912K |
|
270
PUT
Molson Coors Class B
TAP
$7.68B
| $21K | 0.02% |
20,900
+14,300
| +217% | +$1.45M |
|
|
AGN
271
CALL
DELISTED
Allergan plc
AGN
| $21K | 0.02% |
10,800
+500
| +5% | +$122K |
|
272
CALL
Celldex Therapeutics
CLDX
$2.77B
| $20K | 0.02% |
1,667
+1,187
| +247% | +$73.9K |
|
273
PUT
Sarepta Therapeutics
SRPT
$1.82B
| $20K | 0.02% |
105,500
+10,500
| +11% | +$317K |
|
274
CALL
CF Industries
CF
$18.7B
| $19K | 0.02% |
+10,300
| New | +$251K |
|
275
Hershey
HSY
$34.8B
| $19K | 0.02% |
+200
| New | +$21.2K |
|
Similar funds
MC
FIM
TLIC
MKCM
ACM
MFM
VE
GFWEV
FT Options's Q3 2016 Portfolio in Review
As of Q3 2016, FT Options held 493 positions worth $126M, up 8.4% from $116M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
FT Options deployed $224M of net new capital in Q3 2016, opening 153 new positions and adding to 113 existing holdings. Its largest new stake was iShares Biotechnology ETF: 21,000 shares worth $2.03M.
By sector, the portfolio is most concentrated in Healthcare at 40% of assets, down from 41% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $2.74M trimmed.
- FT Options's largest Q3 2016 buy was iShares Biotechnology ETF: 21,000 shares worth $2.03M.
- FT Options added most to Procter & Gamble in Q3 2016, an estimated $3.82M increase.
- FT Options's biggest Q3 2016 reduction was Apple, cutting an estimated $2.74M.
- FT Options fully exited MEDIVATION, INC. in Q3 2016, selling an estimated $7.18M.
- FT Options's ten largest holdings make up 38% of its $126M portfolio in Q3 2016.
- FT Options opened 153 new positions and closed 127 in Q3 2016.
- FT Options's portfolio value rose 8.4% quarter-over-quarter to $126M.
Based on FT Options's 13F filing for Q3 2016, filed 10 Nov 2016.